Positioning political buying, disclosed 2026-09-25
Options put/call open interest 0.59, read 2026-11-03
Ethical passes the values gate
Price102.97 USD
Fair value140.59
Ethical score81.4/100
Value readUndervaluedas of 3 Nov 2026
Our investment reviews on this name
2026-11-01Read Markup104.51-1.5% to today Distribution gives way to Markup first Markup read since October
2026-10-25Read Distribution109.85-6.3% to today ✓Markup gives way to Distribution first Distribution read since October
2026-10-11Read Markup106.70-3.5% to today Distribution gives way to Markup first Markup read since August
2026-09-12Read Distribution109.17-5.7% to today ✓Markup gives way to Distribution after a 10% slide in 5 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Cisco holds its Distribution at $102.97. Consolidating, no directional conviction, held for 18 days.
As held on the ledger · 2026-11-03
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 18 days
Price at the screen
$102.97
Valuation
32.61 trailing · 19.32 forward price to earnings
Values screen
PASS· score 81.4
Beta
0.98
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
22.97%
Below 33%
Interest-bearing debt is just 23.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
6.35%
Below 33%
Cash held in interest-bearing accounts and securities is 6.3% of assets, under the one-third limit.
Pass
Receivables
12.30%
Below 49%
Money owed to the company is 12.3% of assets, under the 49% limit.
Pass
Revenue purity
1.77%
Below 5%
Only 1.8% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Cisco clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 23%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CSCO's ethical verdict changes
Today CSCO passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Cited by BDS movement for providing networking and surveillance technology used by Israeli security forces. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 3 Nov 2026: it trades at roughly a 27% discount to our $140.59 fair value, moderate competitive moat, 17.60% revenue growth.
Fair value range in USD, drawn from the 2026-11-03 screen. The gold marker is the market price at the same screen. A 26.8% discount to the base estimate.
Where our models see it going: fair-value estimate $140.59, with a range of $109.63 to $182.72, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it stands out
A 18%-growth business trading at just 19.3x forward earnings, with a moderate competitive moat. That is a 27% discount to our $140.59 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 25 analysts rate it Buy with a $135.00 average target, about 31% above the screened price.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CSCO trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Markup · changed$104.51-4.9%Entry 17
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter.
2026-10-18Markup$109.85+3.0%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter.
2026-10-11Markup · changed$106.70+0.0%Entry 14
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter.
2026-10-02Distribution$106.70-2.3%Entry 13
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter.
2026-08-12Markup$121.50+0.0%Entry 11
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-11Markup$121.50+0.0%Entry 10
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-09Markup$121.50+0.0%Entry 9
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-08Markup$121.50+0.0%Entry 8
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.